FDA approves Zepzelca for metastatic SCLC June 15, 2020 By Karen Carey Two months earlier than expected, Pharmamar SA and partner Jazz Pharmaceuticals plc received an accelerated FDA approval of Zepzelca to treat relapsed metastatic small-cell lung cancer patients.Read More
RORC antagonists presented by Jiangsu Chia Tai Tianqing Pharmaceutical, Nanjing Gear Pharma & Tech June 15, 2020
Janus kinase inhibitors patented by Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical June 15, 2020
RSS